Found 160 matching trials
A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers PHASE1 RV568 is being developed as a possible treatment of smoking related lung di...
Show More Location
Multiple Locations
Learn More & Join Trial
Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults PHASE1 This study represents the first administration of GSK625433 in humans. The ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects PHASE1 This study is the first administration of GSK2849466 in humans. This will b...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects PHASE1 This study is the first administration of GSK2982772 in humans. The study w...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases. PHASE2 This study will evaluate the efficacy and safety data of AZD8871 in patient...
Show More Learn More & Join Trial
Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients PHASE1 This study will be the first administration of CCI15106 capsules for inhala...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects PHASE1 The current study is designed to assess the safety, tolerability, pharmacok...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects PHASE1 This study is designed to investigate the safety, tolerability and pharmaco...
Show More Location
Richmond Pharmacology
Learn More & Join Trial
Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue PHASE1 The purpose of this study is to determine if two-weeks of dosing with thiam...
Show More Location
SGS Research Unit - Stuivenberg
Learn More & Join Trial
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RO6889678 and the Combination of RO6889678 With Ritonavir in Healthy Participants PHASE1 This study is a single-center, double-blind, randomized, placebo-controlled...
Show More Location
Centre For Human Drug Research; Research
Learn More & Join Trial